Jennifer Kayden Lee - 09 Feb 2023 Form 4/A - Amendment Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role: EVP, Head of North America
Signature: /s/ Hunter Smith, Attorney-in-Fact for Jennifer Chien
Issuer symbol: RYTM
Transactions as of: 09 Feb 2023
Net transactions value: -$33,122
Form type: 4/A - Amendment
Filing time: 14 Feb 2023, 18:19:04 UTC
Date Of Original Report: 13 Feb 2023
Previous filing: 03 Feb 2023
Next filing: 14 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RYTM	Common Stock	Sale	$33,122	-1,204	-25%	$27.51	3,544	09 Feb 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The sales reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units.

Remarks:

This amended Form 4 is being filed solely for the purpose of correcting an administrative error in the number of shares sold and sale price which were initially reported on the Form 4 filed on February 13, 2023.